OTX-008

Star0

DB13123InvestigationalSmall molecule

OTX008 has been used in trials studying the treatment of Solid Tumors.

Mechanism: Pharmacologically active on Galectin-1
Curator reviewed
Formula / weight: C₅₂H₇₂N₈O₈ · 937.196 g/mol (avg)
Code names: CALIXARENE 0118 · KM-0118 · OTX008 · PTX-008

Resolves to

Compound

UNII8JI63CFH5VCAS286936-40-1ChEMBLCHEMBL221186PubChem11953346

Structure

InChIKeyCQVAQQNDZCZBSU-UHFFFAOYSA-NSMILESCN(C)CCNC(=O)COC1=C2CC3=CC=CC(CC4=CC=CC(CC5=C(OCC(=O)NCCN(C)C)C(CC1=CC=C2)=CC=C5)=C4OCC(=O)NCCN(C)C)=C3OCC(=O)NCCN(C)C

Targets

P09382LGALS1

What you can answer from here — as of May 05, 2022

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with OTX-008, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account